Naloxegol
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Constipation, Signs and Symptoms, Digestive
Conditions
Constipation, Signs and Symptoms, Digestive
Trial Timeline
Nov 1, 2014 → Apr 1, 2021
NCT ID
NCT02099591About Naloxegol
Naloxegol is a phase 1 stage product being developed by Kyowa Kirin for Constipation, Signs and Symptoms, Digestive. The current trial status is completed. This product is registered under clinical trial identifier NCT02099591. Target conditions include Constipation, Signs and Symptoms, Digestive.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03638440 | Pre-clinical | Completed |
| NCT04173858 | Pre-clinical | Completed |
| NCT02813148 | Pre-clinical | Completed |
| NCT02099591 | Phase 1 | Completed |
Competing Products
20 competing products in Constipation, Signs and Symptoms, Digestive